Conference Program
Tuesday 13th November 2007
SESSION 5:
ADJUVANT DEVELOPMENTS – I
Moderator: Gwyn Davies (St. George’s University of London, UK)
09.00-09.30
‘Aluminium-containing adjuvants: Properties, formulation and use’
Stanley Hem (Purdue University, USA)
09.30-10.00
‘The TLR9 agonist VaxImmune (CPG 7909) is a potent vaccine adjuvant for prophylactic and therapeutic vaccines’
Heather L. Davis (Coley Pharmaceutical Group, Ottawa, Ontario, Canada)
10.00-10.30
‘Latest developments with ISCOMATRIX™ adjuvant’
Debbie Drane (CSL Ltd., Victoria, Australia)
10.30-11.00
Coffee & Posters
SESSION 6:
ADJUVANT DEVELOPMENTS – II
Moderator: Ed Lavelle (Trinity College, Dublin, Ireland)
11.00-11.30
‘New paradigms in the development of novel adjuvants’
Karen Lingnau (Intercell AG, Vienna, Austria)
11.30-12.00
‘Immune adjuvant activity of mycobacterial cell wall components’
M.C. Filion, C. Ciurli, M. Lehoux, B. Filion, N. Saha, D. Ke and N.C. Phillips (Bioniche Life Sciences Inc., Montreal, Canada)
12.00-12.30
‘An effective adjuvant based on a novel in-situ gelling anionic polysaccharide (GelSite polymer)’
Yawei Ni et al. (DelSite Biotechnologies Inc., Irving, Texas, USA)
12.30-14.00
Lunch & Posters
SESSION 7:
DELIVERY
Moderator: Jean Haensler (Sanofi Pasteur, France)
14.00-14.30
‘Electroporation in the clinic: devices, procedures and tolerability’
Iacob Mathiesen, Torunn E. Tjelle, Rune Kjeken, David Dearnaly and Christian Ottensmeier (Inovio A/S, Oslo, Norway)
14.30-15.00
‘Clinical technology for electroporation based DNA vaccine delivery: Moving towards prophylactic indications’
Drew Hannaman (ICHOR Medical Systems, San Diego, California, USA)
15.00-15.30
‘Immunostimulation with reconstituted influenza virosomes’
Rinaldo Zurbriggen (Pevion Biotech Ltd., Berne, Switzerland)
15.30-16.00
‘Nasal immunization – facts, fiction, future’
Ulf Schroder (Eurocine Vaccines, Stockholm, Sweden)
16.00 -16.30
Tea & Posters
SESSION 8:
TRANSCUTANEOUS IMMUNIZATION/SKIN DELIVERY
Moderators: Greg Glenn (IOMAI Inc., Maryland, USA) and John Clements (Tulane University, New Orleans, USA)
16.30-16.50
‘Skin immunology and adjuvants’
Marcel Teunissen (University of Amsterdam, The Netherlands)
16.50-17.10
‘LT and related adjuvants, mechanisms, related to transcutaneous immunization’
John Clements (Tulane University, New Orleans, USA)
17.10-17.30
‘The effects of LT on migrating dendritic cells’
Simon Milling (University of Oxford, UK)
17.30-17.50
‘Transcutaneous immunization in Phase 2: Recent developments in formulation and delivery’
Gregory Glenn (IOMAI Inc., Maryland, USA)
Session 8 sponsored by IOMAI Inc.
Free Evening for Delegates